 |
|
Group B Streptococcus Bacteremia in Nonpregnant Adults
Patricia Muñoz, MD;
Alvaro Llancaqueo, MD;
Marta Rodríguez-Créixems, MD;
Teresa Peláez, PharmD, PhD;
Luisa Martin, MD;
Emilio Bouza, MD, PhD
Arch Intern Med. 1997;157(2):213-216.
Abstract
| |
Background
We report the largest series of group B streptococcal (GBS) bacteremia cases reported at a single institution.
Methods
During a 10-year period (1985-1994), 90 GBS bacteremia cases (0.95% of significant bacteremic episodes) were detected. We describe the 51 episodes that occurred in nonpregnant adults for which enough clinical and microbiological information is available.
Results
Incidence of GBS has significantly increased during the study period (from 0.08 per 1000 admissions in 1985 to 0.3 per 1000 in 1994). Mean age of patients was 63.3 years (range, 21-88 years) and 53% were men. The most common underlying conditions were liver diseases (35.3%), malignancies (33.3%), and diabetes mellitus (27.5%). Only 2 patients did not have any underlying condition and no patient with the human immunodeficiency virus had GBS bacteremia in our series. The origins of the episodes of bacteremia were as follows: primary bacteremia (39.2%), skin and soft tissue infections (15.7%), urinary tract infections (11.8%), pneumonia (9.8%), peritonitis (9.8%), catheter infection (5.9%), postendoscopic bacteremia (5.9%), and endocarditis (2%). All isolates were susceptible to penicillin G potassium, ampicillin sodium, cephalothin sodium, cefotaxime sodium, and vancomycin hydrochloride. One ciprofloxacin hydrochloride—resistant strain was discovered and resistance to erythromycin stearate increased from 8% in 1992 to 18% in 1994. The overall mortality rate was 33.3% and deaths were considered related to the GBS bacteremia in 25.5% of the cases. Factors for poor prognosis were central nervous system diseases, alcoholism, shock, renal failure, and consciousness impairment.
Conclusions
Group B streptococcus is a rising cause of bacteremia in elderly patients with severe underlying conditions. It conveys high morbidity and mortality rates. Macrolides should not be used empirically for treatment of patients with penicillin allergies.
Arch Intern Med. 1997;157:213-216
Author Affiliations
From the Department of Microbiology, Hospital General Universitario Gregorio Marañon, Madrid, Spain. Dr Llancaqueo is now with the Hospital Las Higueras, Talcahuano, Chile.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Diversity and complexity of urinary tract infection in diabetes mellitus
Hakeem et al.
British Journal of Diabetes & Vascular Disease 2009;9:119-125.
ABSTRACT
Streptozocin-Induced Diabetic Mouse Model of Urinary Tract Infection
Rosen et al.
Infect. Immun. 2008;76:4290-4298.
ABSTRACT
| FULL TEXT
Type I IFN Signaling Is Crucial for Host Resistance against Different Species of Pathogenic Bacteria
Mancuso et al.
J. Immunol. 2007;178:3126-3133.
ABSTRACT
| FULL TEXT
Group B Streptococcal Toxic Shock-Like Syndrome
Reich et al.
Arch Dermatol 2004;140:163-166.
FULL TEXT
Susceptibility to antimicrobials and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae from Rio de Janeiro, Brazil
d'Oliveira et al.
J Med Microbiol 2003;52:1029-1030.
FULL TEXT
Group B streptococcal conjugate vaccines
Baker and Edwards
Arch. Dis. Child. 2003;88:375-378.
ABSTRACT
| FULL TEXT
Mitogen-Activated Protein Kinases and NF-{kappa}B Are Involved in TNF-{alpha} Responses to Group B Streptococci
Mancuso et al.
J. Immunol. 2002;169:1401-1409.
ABSTRACT
| FULL TEXT
Capsulate bacteria and the lung: Childhood respiratory infections
Buttery and Moxon
Br Med Bull 2002;61:63-80.
ABSTRACT
| FULL TEXT
Prevalence and Mechanisms of Macrolide Resistance in Invasive and Noninvasive Group B Streptococcus Isolates from Ontario, Canada
de Azavedo et al.
Antimicrob. Agents Chemother. 2001;45:3504-3508.
ABSTRACT
| FULL TEXT
Survival of Group B Streptococcus Type III in Mononuclear Phagocytes: Differential Regulation of Bacterial Killing in Cord Macrophages by Human Recombinant Gamma Interferon and Granulocyte-Macrophage Colony-Stimulating Factor
Marodi et al.
Infect. Immun. 2000;68:2167-2170.
ABSTRACT
| FULL TEXT
Haemophilus ducreyi Produces a Novel Sialyltransferase. IDENTIFICATION OF THE SIALYLTRANSFERASE GENE AND CONSTRUCTION OF MUTANTS DEFICIENT IN THE PRODUCTION OF THE SIALIC ACID-CONTAINING GLYCOFORM OF THE LIPOOLIGOSACCHARIDE
Bozue et al.
J. Biol. Chem. 1999;274:4106-4114.
ABSTRACT
| FULL TEXT
|
